wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738850-0D26BCF9-5149-4772-B434-6CCE3144F845
Q26738850-0D26BCF9-5149-4772-B434-6CCE3144F845
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738850-0D26BCF9-5149-4772-B434-6CCE3144F845
Schizophrenia relapse, patient considerations, and potential role of lurasidone
P2860
Q26738850-0D26BCF9-5149-4772-B434-6CCE3144F845
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738850-0D26BCF9-5149-4772-B434-6CCE3144F845
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e0d0291c1d7e6b082224ef1d6050c2f67b1f3ed5
P2860
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.